Stem Cell Manufacturing Market: Information by Application (Therapy & Research & Cell), Product (Stem Cell Lines and Instruments, Consumables & Culture Media), End User (Pharmaceutical/Biotechnology Companies & CRO), & Region - Global Forecast till 2027

Market Analysis

The global stem cell manufacturing market is eyeing for a healthy growth at an impressive 6.6% CAGR over the estimated years (2018-2023). Stem cell manufacturing simply put is used for extracting cells from the bone marrow or peripheral blood cells. The cells which are extracted are generally cultured in a dish containing nutrient media. In fact, stem cells are isolated from umbilical cord blood, placenta, amniotic sac & fluid, adipose tissue and menstrual blood.

There are plentiful factors that is boosting the growth of the stem cell manufacturing market. These factors as per the Market Research Future (MRFR) report include increasing funding and public-private investments in research that is stem cell-based, growing public awareness about stem cell products therapeutic potency, creation of latest genomic analysis methods for quality control at the time of stem cell manufacturing, advancements in technology in manufacturing and preservation of stem cell, and evolving regulatory frameworks exclusively for stem cell therapeutics. On the contrary, stringent regulations on stem cell manufacturing coupled with high expenditure of research and manufacturing processes are factors that may impede stem cell manufacturing market growth over the estimated years.

Request Free Sample Copy at : https://www.marketresearchfuture.com/sample_request/6942

Market Segmentation

MRFR report provides an extensive segmental analysis of the stem cell manufacturing market on the basis of application, product and end-user.

By product, it is segmented into culture media, consumables, stem cell lines and instruments. The stem cell lines segment is further segmented into mesenchymal stem cells (MSCs), embryonic stem cell (ESC), induced pluripotent stem cell (iPSC), hematopoietic stem cells (HSCs) and others. Among these, culture media will have the largest share in the market over the estimated years.

By application, it is segmented into therapy, research, target identification and cell & tissue banking. The therapy segment is further divided into autologous and allogeneic. Among these, the cell & tissue banking segment will dominate the market over the estimated years followed by research that is predicted to grow at the fastest pace.

By end-user, it is segmented into pharmaceutical & biotechnology companies, stem cell banks, hospitals and others. Among these, pharmaceutical & biotech companies will head the market over the estimated years.

Regional Analysis

By region, the stem cell manufacturing market is segmented into North America, Europe, Asia Pacific and Middle East and Africa. Among these, North America is anticipated to govern the market over the estimated years. This is owing to increasing investments being made in research and development related to healthcare, therapeutic potency of the stem cells and growing public-private funding. The stem cell manufacturing market in the European region will have the second major share due to in-depth research on stem cell in this region. In the APAC region the stem cell manufacturing market will grow at the fastest pace on account of growing awareness regarding the therapeutic uses associated to stem cells and expanding biotechnology industry in this region. In the Middle East and Africa, the stem cell manufacturing market will accrue small share over the estimated years yet its growth however is prognosticated to be driven via the growing healthcare infrastructure.

Key Players

Merck KGaA, Thermo Fisher Scientific, BD, Bristol-Myers Squibb Company, AbbVie Inc., Lonza, Bio-Rad Laboratories, Inc., Takeda Pharmaceutical Company Limited, GlaxoSmithKline plc, Teva Pharmaceutical Industries Ltd., American CryoStem Corporation, STEMCELL Technologies Inc, Takara Bio Inc., Miltenyi Biotec, and FUJIFILM Cellular Dynamics, Inc. (FCDI) are the leading players profiled in the stem cell manufacturing market.

April 2019- Researchers at the Institute for Molecular Engineering have created a “lab-on-a-chip” which will help people to understand as to how single stem cells will react to various molecules and environments. This chip can help in examining thousands of single live cells within a weeklong period and also perform experiments which in case of a laboratory will take over 1 million steps. The credit-card sized device along with saving money and time will also provide a new glimpse regarding how an individual stem cell will react to various environments and molecules. This microfluidic device can sort, culture and image individual cells in a high-throughput and automated way.

Browse Detailed TOC with COVID-19 Impact Analysis at: https://www.marketresearchfuture.com/reports/stem-cell-manufacturing-market-6942

Contact:

Akash Anand

Market Research Future

+1 646 845 9312

Email: [email protected]